Profound Medical Corp.
corporate_fare Company Profile
Profound Medical Corp. (NASDAQ:PROF) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 29 items for PROF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for PROF spans 8-K, 10-Q, S-3.
Recent high-impact activity:
- Profound Sets CEO Succession: Fabian to CEO Jan 15, 2027; Menawat to Executive Chairman
- Profound 10-Q: Q3 Revenue $9.8M, Cash Falls to $33.3M, Loan Now Current
- Profound Q3 Revenue Up 86% to $9.8M; Sets $25M Full-Year Floor and Names Fabian CEO
- Profound Signs Cook Medical Distribution Deal for TULSA-PRO in U.S. iMRI Suites
- Profound Medical's TULSA-PRO Shows Superior Erectile Function Preservation vs Robotic Surgery in CAPTAIN Trial
Financial Snapshot
Short Interest & Short Volume
9.83 days to coverFINRA reported short interest of 1,580,524 shares in PROF as of the October 30, 2026 settlement, a 1.5% increase from the prior period — about 9.8 days to cover at its recent average daily volume. On November 20, 2026, 48.3% of PROF volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.